NPM1 gene mutations can be confidently identified in blood DNA months before de novo AML onset.

Blood Adv

Wellcome-Medical Research Council Cambridge Stem Cell Institute, Department of Haematology, University of Cambridge, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, United Kingdom.

Published: April 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006299PMC
http://dx.doi.org/10.1182/bloodadvances.2021005927DOI Listing

Publication Analysis

Top Keywords

npm1 gene
4
gene mutations
4
mutations confidently
4
confidently identified
4
identified blood
4
blood dna
4
dna months
4
months novo
4
novo aml
4
aml onset
4

Similar Publications

A 32-year-old man had recurrent abdominal pain and vomiting for 2 weeks. Physical examination revealed a 4×2-cm abdominal tough mass with unclear boundaries. Palpation caused mild tenderness without rebound pain.

View Article and Find Full Text PDF

The clinical features and outcomes of elderly patients with acute myeloid leukemia: a real word research.

Clin Exp Med

January 2025

Medical Center of Hematology, Xinqiao Hospital of Army Medical University; Chongqing Key Laboratory of Hematology and Microenvironment; State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing, No.83 Xinqiao Main Street, Shapingba District, 400037, China.

The aim of this study was to investigate the clinical features and outcomes of elderly patients with acute myeloid leukemia (AML) from a real word research. The clinical data of 223 consecutive elderly patients (aged ≥ 60 years) who were newly diagnosed with AML at our medical center between July 2017 and June 2022, including their clinical characteristics, genetic mutations, and survival outcomes, were retrospectively analyzed. Among the 223 patients (median age 67 years), 180 (80.

View Article and Find Full Text PDF

Objective: To explore the characteristics of gene mutation in patients with myelodysplastic syndrome (MDS) and its correlation with clinical features.

Methods: From January 2017 to December 2021, 172 patients with MDS in The First Affiliated Hospital of Bengbu Medical University were analyzed retrospectively. Fourteen high frequency genes related to MDS were detected, and the relationship between gene mutation and clinical characteristics of patients as well as revised International Prognostic Scoring System (IPSS-R) was analyzed.

View Article and Find Full Text PDF

Pluripotent stem cells possess a unique nuclear architecture characterized by a larger nucleus and more open chromatin, which underpins their ability to self-renew and differentiate. Here, we show that the nucleolus-specific RNA helicase DDX18 is essential for maintaining the pluripotency of human embryonic stem cells. Using techniques such as Hi-C, DNA/RNA-FISH, and biomolecular condensate analysis, we demonstrate that DDX18 regulates nucleolus phase separation and nuclear organization by interacting with NPM1 in the granular nucleolar component, driven by specific nucleolar RNAs.

View Article and Find Full Text PDF
Article Synopsis
  • This study identified a subgroup of acute myeloid leukemia (AML) patients with an APL-like immunophenotype characterized by the absence of CD34 and HLA-DR, aiming to explore differences in clinical and molecular features between them and regular AML patients.
  • Out of 191 patients analyzed, 32 exhibited this specific immunophenotype and were found to have a higher risk of developing disseminated intravascular coagulation (DIC) and showed distinct molecular characteristics, including more frequent NPM1 mutations and higher WT1 gene expression.
  • Despite being in a favorable risk category based on some parameters, patients with the CD34HLA-DR immunophenotype experienced shorter overall survival, underscoring the need
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!